Physician profile
Michael E Vega
NPI 1578639134
$476.62
in general payments reported to CMS, 2019-2025
12 companies · $16.72 in 2025
The $16.72 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $63.22 · 2021: $63.94 · 2022: $50.28 · 2023: $19.81 · 2024: $62.19 · 2025: $16.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.91 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.91 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $174.06 | 2019-2023 | Bridion |
| Abbvie INC. | $84.46 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $44.06 | 2019 | |
| Ambu INC. | $30.22 | 2024-2025 | |
| Karl Storz Endoscopy-America | $23.36 | 2019 | |
| Acacia Pharma INC | $22.01 | 2022 | |
| Mallinckrodt Hospital Products INC. | $20.71 | 2020 | |
| Lilly USA, LLC | $17.16 | 2024 | Zepbound, Omvoh |
| Intercept Pharmaceuticals, INC. | $16.56 | 2024 | |
| Medtronic, INC. | $14.97 | 2024 | Mcgrath Mac |
| Ge Healthcare | $14.92 | 2019 | |
| Alcon Vision LLC | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.